Description
An inhibitor of IκBα ubiquitylation; inhibits ubiquitylation of phosphorylated IκBα mediated by the SCFβTrCP1 E3 ubiquitin ligase complex in vitro (IC50 = 5.2 μM); reduces TNF-α-induced degradation of phosphorylated IκBα, but not β-catenin, in HeLa S3 cells; inhibits LPS-induced expression of TNF-α, IL-6, IL-12, ICAM-1, and NF-κB in THP-1 cells a concentration-dependent manner; intranasal administration reduces the number of eosinophils, lymphocytes, and total cells in BALF in an ovalbumin-sensitized mouse model of allergic asthma at 32 μg/animal
Formal name: 4-[4-[[5-(2-fluorophenyl)-2-furanyl]methylene]-4,5-dihydro-5-oxo-3-(phenylmethyl)-1H-pyrazol-1-yl]-benzoic acid
Synonyms:
Molecular weight: 466.5
CAS: 916232-21-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|TNF-α/NF-κB Signaling||Research Area|Immunology & Inflammation|Allergy||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma